| |
Merck & Co., Inc. announced a voluntary withdrawal of Vioxx® from the U.S. and worldwide markets on September 24, 2004 due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients on Vioxx®. Vioxx® is a prescription COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) that was approved by FDA in May 1999 for the relief of the signs and symptoms of osteoarthritis, for the management of acute pain in adults, and for the treatment of menstrual symptoms, and was later approved for the relief of the signs and symptoms of rheumatoid arthritis in adults and children.
learn
more about Vioxx >>
If you or someone
you know has taken Vioxx® and has
suffered a
heart attack, stroke, high blood pressure,
seizures, or other related health problems
call us now to protect your legal rights.
|